Michael M. Vickers

2.1k total citations
75 papers, 950 citations indexed

About

Michael M. Vickers is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michael M. Vickers has authored 75 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Michael M. Vickers's work include Colorectal Cancer Treatments and Studies (28 papers), Colorectal Cancer Surgical Treatments (19 papers) and Colorectal and Anal Carcinomas (16 papers). Michael M. Vickers is often cited by papers focused on Colorectal Cancer Treatments and Studies (28 papers), Colorectal Cancer Surgical Treatments (19 papers) and Colorectal and Anal Carcinomas (16 papers). Michael M. Vickers collaborates with scholars based in Canada, United States and Australia. Michael M. Vickers's co-authors include Rachel Goodwin, Patricia A. Tang, Timothy R. Asmis, Daniel Y.C. Heng, Derek J. Jonker, Winson Y. Cheung, Anthony R. MacLean, Soundouss Raissouni, Erin Powell and Jose Gerard Monzon and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Michael M. Vickers

70 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael M. Vickers Canada	19	518	310	269	262	222	75	950
Chiao‐En Wu Taiwan	17	499 1.0×	280 0.9×	289 1.1×	154 0.6×	262 1.2×	92	933
Jurjees Hasan United Kingdom	15	371 0.7×	197 0.6×	326 1.2×	185 0.7×	150 0.7×	53	919
Anne Moore United States	14	770 1.5×	145 0.5×	198 0.7×	399 1.5×	124 0.6×	30	1.2k
Chunxiao Wu China	19	543 1.0×	377 1.2×	299 1.1×	248 0.9×	246 1.1×	47	1.1k
Aytuğ Üner Türkiye	15	400 0.8×	189 0.6×	131 0.5×	105 0.4×	182 0.8×	70	786
Concetta Elisa Onesti Italy	16	465 0.9×	287 0.9×	334 1.2×	255 1.0×	97 0.4×	58	937
Àngels Arcusa Spain	16	616 1.2×	302 1.0×	97 0.4×	234 0.9×	156 0.7×	34	1.0k
Jamal Zekri Saudi Arabia	14	653 1.3×	367 1.2×	190 0.7×	137 0.5×	118 0.5×	68	945
Marek Pudełko Poland	16	920 1.8×	160 0.5×	255 0.9×	165 0.6×	472 2.1×	42	1.3k
Fernando Lara-Medina Mexico	17	487 0.9×	198 0.6×	201 0.7×	411 1.6×	61 0.3×	40	906

Countries citing papers authored by Michael M. Vickers

Since Specialization

Citations

This map shows the geographic impact of Michael M. Vickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Vickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Vickers more than expected).

Fields of papers citing papers by Michael M. Vickers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Vickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Vickers. The network helps show where Michael M. Vickers may publish in the future.

Co-authorship network of co-authors of Michael M. Vickers

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Vickers. A scholar is included among the top collaborators of Michael M. Vickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Vickers. Michael M. Vickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahmed, Atique U., et al.. (2025). Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 43(4_suppl). 304–304. 1 indexed citations

Chénard-Poirier, Maxime, Ravi Ramjeesingh, Vimoj Nair, et al.. (2023). Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023. Current Oncology. 30(9). 8172–8185.

Wong, Boaz, Michael M. Vickers, & Paul Wheatley‐Price. (2021). The Diminishing Importance of Primary Site Identification in Cancer of Unknown Primary: A Canadian Single-Center Experience. Frontiers in Oncology. 11. 634563–634563. 5 indexed citations

Batra, Atul, Ravi Ramjeesingh, Brandon M. Meyers, et al.. (2021). Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study.. Journal of Clinical Oncology. 39(3_suppl). 385–385.

Stacey, Dawn, Lynne Jolicoeur, Meg Carley, et al.. (2020). Quality of telephone-based cancer symptom management by nurses: a quality improvement project. Supportive Care in Cancer. 29(2). 841–849. 9 indexed citations

Dudani, Shaan, Patricia A. Tang, Jose Gerard Monzon, et al.. (2019). Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 19(1). 664–664. 50 indexed citations

Vickers, Michael M., et al.. (2019). Physician-reported reasons for non-enrollment of older adults in cancer clinical trials. Journal of Geriatric Oncology. 11(1). 31–36. 13 indexed citations

Mulder, Karen, Christine Brezden‐Masley, Michael M. Vickers, et al.. (2018). A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. Investigational New Drugs. 36(4). 674–682. 1 indexed citations

Cheung, Winson Y., Han‐Bo Zhang, Patricia A. Tang, et al.. (2018). A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 36(4_suppl). 476–476. 1 indexed citations

10.

Jonker, Derek J., Louise Nott, Takayuki Yoshino, et al.. (2016). A randomized phase III study of napabucasin [BBI608] (NAPA) vs placebo (PBO) in patients (pts) with pretreated advanced colorectal cancer (ACRC): the CCTG/AGITG CO.23 trial. Annals of Oncology. 27. vi150–vi150. 13 indexed citations

11.

Bossé, Dominick, Soundouss Raissouni, Kristopher Dennis, et al.. (2016). PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium. Clinical Colorectal Cancer. 15(3). 243–249. 21 indexed citations

12.

Loree, Jonathan M., Hagen F. Kennecke, Daniel J. Renouf, et al.. (2016). Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy. Clinical Colorectal Cancer. 15(4). 352–359.e1. 11 indexed citations

13.

Jiang, Di, Soundouss Raissouni, Anjali S. Kumar, et al.. (2015). Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer. Annals of Oncology. 26(10). 2102–2106. 22 indexed citations

14.

Bossé, Dominick, Michael M. Vickers, Frédéric Lemay, & Audrée Jeanne Beaudoin. (2015). Palliative Chemotherapy for Patients 70 Years of Age and Older with Metastatic Colorectal Cancer: A Single-Centre Experience. Current Oncology. 22(5). 349–356. 7 indexed citations

15.

Raissouni, Soundouss, et al.. (2015). Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer. BMC Research Notes. 8(1). 538–538. 3 indexed citations

16.

Raissouni, Soundouss, Julie Price Hiller, Erin Powell, et al.. (2015). Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study. Clinical Colorectal Cancer. 14(4). 291–295. 53 indexed citations

17.

Yeung, Raymond S., Yarrow J. McConnell, Rintu Banerjee‬‬‬‬‬‬‬‬‬, et al.. (2014). One Compared with Two Cycles of Mitomycin C in Chemoradiotherapy for Anal Cancer: Analysis of Outcomes and Toxicity. Current Oncology. 21(3). 449–456. 22 indexed citations

18.

Vickers, Michael M., Janice L. Pasieka, Elijah Dixon, et al.. (2012). Report from the 13th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; September 8–10, 2011. Current Oncology. 19(6). 468–477. 1 indexed citations

19.

Vickers, Michael M., Jair Bar, Nirit Yarom, et al.. (2011). Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clinical & Experimental Metastasis. 29(2). 123–132. 99 indexed citations

20.

Vickers, Michael M. & Jacob C. Easaw. (2008). Palmar–Plantar Hyperpigmentation with Capecitabine in Adjuvant Colon Cancer. Journal of Gastrointestinal Cancer. 39(1-4). 141–3. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact